MCC950 compound abrogates oxLDL-induced increase in pro-IL-1β protein expression.

THP-1 cells were exposed to oxLDL, the NLRP3 inhibitor MCC950 (MCC) or their combination (MCC+OxL). Cell lysates were subjected to SDS-PAGE and immunoblotted with anti-pro-IL-1β (upper panel) or anti-vinculin antibody (bottom panel), as indicated. The band densities, relative to vinculin (loading control), were quantified using ImageJ (NIH, Bethesda, MD). Veh, vehicle. N = 3/group, * P<0.05 vs Veh, one-way ANOVA, Newman-Keuls test.

(TIF)